Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 October to Question 96854, when the Medicines and Healthcare products Regulatory Agency will establish a registry of all women and girls of childbearing in receipt of prescriptions for sodium valproate.

The Medicines and Healthcare products Regulatory Agency is working with NHS Digital to develop a registry to monitor the use of valproate and compliance with the current regulatory position, and to monitor any children born to women on valproate. Completion of the first stage of the registry which will provide information on all women currently prescribed valproate in England is planned by the end of the year.